Trust Co. of Toledo NA OH Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Trust Co. of Toledo NA OH lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,654 shares of the healthcare conglomerate’s stock after selling 21 shares during the period. Trust Co. of Toledo NA OH’s holdings in UnitedHealth Group were worth $3,306,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Swedbank AB purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at about $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after acquiring an additional 1,196,758 shares during the last quarter. Lone Pine Capital LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $480,903,000. Dimensional Fund Advisors LP increased its position in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares during the period. Finally, Baillie Gifford & Co. boosted its holdings in shares of UnitedHealth Group by 1,125.4% in the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after acquiring an additional 821,050 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Royal Bank of Canada upped their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. HSBC lifted their target price on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. UBS Group increased their price target on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Finally, Barclays boosted their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $614.17.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $592.30 on Thursday. The company’s 50-day moving average price is $581.15 and its 200 day moving average price is $526.18. The stock has a market cap of $546.94 billion, a price-to-earnings ratio of 36.20, a PEG ratio of 1.62 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the company earned $6.14 earnings per share. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.